In 2010, it was shown that the drug Comtan (active component: entacapone) that treats Parkinson’s disease can potentially be repurposed to treat multidrug-resistant and extremely-drug resistant forms of tuberculosis.51 Comtan is an inhibitor of COMT, which is one of the SZ-associated genes. Here, COMT is linked to Parkinson disease.